The Department of Commerce launched an investigation on April 1 into the national security impacts of importing drugs and active pharmaceutical ingredients.

Dementia is the UK's biggest killer, claiming more lives than heart attacks and strokes combined. Despite exhaustive research, science has failed to find a cure or drug to prevent it.

Times Change’ was recorded for Alzheimer’s Tea Day on May 1 in memory of his mother-in-law and everyone who has the condition ...

Prof. Daniel Drucker’s pioneering work on GLP-1, in collaboration with world-renowned scientists, has transformed treatment for diabetes and obesity - and is now opening new frontiers in ...

Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined Alzheimer’s Research UK in 2013 and has overseen significant growth in income in recent years, which has ...

In summary, GLP-1 receptor agonists, originally used to treat diabetes, are now being explored for brain protection. Two ...

A U.S. senator said a GLP-1 drug changed his life — and now he’s calling for widespread access to anti-obesity medications.

Pa., said Mounjaro changed his life with 'significant' health benefits. He's calling for widespread access to GLP-1 ...

The study supports prior research that found the same thing.

Dementia, including Alzheimer’s disease and related disorders, is one of the fastest-growing public health concerns globally. It currently affects over 55 million people and is expected to impact 139 ...

Denmark’s economy was reshaped by Novo Nordisk and obesity drugs. That identity now is under attack on multiple fronts, from ...

Heavy drinkers have an increased risk of developing brain lesions associated with memory and thinking problems, a new study ...